0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibiotics Market Insights, Forecast to 2028
Published Date: March 2022
|
Report Code: QYRE-Auto-28H9591
Home | Market Reports | Health | Health Conditions | Infectious Diseases
Global Antibiotics Market Insights Forecast to 2028

Global Antibiotics Market Insights, Forecast to 2028

Code: QYRE-Auto-28H9591
Report
March 2022
105 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Global Antibiotics Market

Due to the COVID-19 pandemic, the global Antibiotics market size is estimated to be worth USD 44770 Million in 2022 and is forecast to a readjusted size of USD 54400 Million by 2028 with a CAGR of 3.3% during the review period.

Antibiotics Market Overview

Antibiotic also called an antibacterial, is a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. A limited number of antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza; drugs which inhibit viruses are termed antiviral drugs or antivirals rather than antibiotics.

Fully considering the economic change by this health crisis, Cephalosporins accounting for % of the Antibiotics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

More than 15.0% of the deaths, in children below the age of five, are estimated to be due to pneumonia and according to the statistics provided by the WHO about 9.2 million deaths were recorded in 2015. Similar to tuberculosis, the highest prevalence of the disease is identified to be in the South Asian and Sub-Saharan regions. Currently, the required antibiotic treatment is available only to one third of the infected population, thereby increasing the disease burden.

Antibiotics market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antibiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

By Type

  • Cephalosporins
  • Penicillins
  • Fluoroquinolones
  • Macrolides
  • Carbapenems
  • Aminoglycosides
  • Sulfonamides
  • Others

By Application

  • Hospital
  • Clinics
  • Others

By Company

  • Pfizer
  • Janssen Pharmaceuticals
  • Abbott
  • GlaxoSmithKline
  • Sanofi
  • Novartis
  • Bayer
  • Bristol Myers Squibb Company
  • Eli Lilly and Company
  • Astellas Pharma

By Region

  • North America
  • US.
  • Canada
  • Europe
  • Germany
  • France
  • UK.
  • Italy
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Taiwan
  • Indonesia
  • Thailand
  • Malaysia
  • Philippines
  • Vietnam
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • U.A.E

Scope of Antibiotics Market Report

Report Metric

Details

Report Name

Antibiotics Market

Market size value in 2022

USD 44770 Million

Revenue forecast in 2028

USD 54400 Million

Growth Rate

3.3%

Base year considered

2022

Forecast Period

2023-2028

By Type

Cephalosporins, Penicillins, Fluoroquinolones, Macrolides, 

Carbapenems, Aminoglycosides, Sulfonamides

By Application

Hospitals, Clinics

Report Coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Segments Covered

By Type, Application, and Region

Geographic Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report 

1. How big is the Antibiotics Market?

Ans. The global Antibiotics Market will grow at a CAGR of 3.3%

2. Who are the key players available in the Antibiotics Industry?

Ans. Some of the major companies are Pfizer, Janssen Pharmaceuticals, Abbott, GlaxoSmithKline, Sanofi, Novartis, Bayer, Bristol Myers Squibb Company, Eli Lilly and Company, Astellas Pharma.

3. Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

1 Study Coverage
1.1 Antibiotics Product Introduction
1.2 Market by Type
1.2.1 Global Antibiotics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cephalosporins
1.2.3 Penicillins
1.2.4 Fluoroquinolones
1.2.5 Macrolides
1.2.6 Carbapenems
1.2.7 Aminoglycosides
1.2.8 Sulfonamides
1.2.9 Others
1.3 Market by Application
1.3.1 Global Antibiotics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibiotics Sales Estimates and Forecasts 2017-2028
2.2 Global Antibiotics Revenue Estimates and Forecasts 2017-2028
2.3 Global Antibiotics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antibiotics Sales by Region
2.4.1 Global Antibiotics Sales by Region (2017-2022)
2.4.2 Global Sales Antibiotics by Region (2023-2028)
2.5 Global Antibiotics Revenue by Region
2.5.1 Global Antibiotics Revenue by Region (2017-2022)
2.5.2 Global Antibiotics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antibiotics Sales by Manufacturers
3.1.1 Global Top Antibiotics Manufacturers by Sales (2017-2022)
3.1.2 Global Antibiotics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antibiotics in 2021
3.2 Global Antibiotics Revenue by Manufacturers
3.2.1 Global Antibiotics Revenue by Manufacturers (2017-2022)
3.2.2 Global Antibiotics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antibiotics Revenue in 2021
3.3 Global Antibiotics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antibiotics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antibiotics Sales by Type
4.1.1 Global Antibiotics Historical Sales by Type (2017-2022)
4.1.2 Global Antibiotics Forecasted Sales by Type (2023-2028)
4.1.3 Global Antibiotics Sales Market Share by Type (2017-2028)
4.2 Global Antibiotics Revenue by Type
4.2.1 Global Antibiotics Historical Revenue by Type (2017-2022)
4.2.2 Global Antibiotics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antibiotics Revenue Market Share by Type (2017-2028)
4.3 Global Antibiotics Price by Type
4.3.1 Global Antibiotics Price by Type (2017-2022)
4.3.2 Global Antibiotics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antibiotics Sales by Application
5.1.1 Global Antibiotics Historical Sales by Application (2017-2022)
5.1.2 Global Antibiotics Forecasted Sales by Application (2023-2028)
5.1.3 Global Antibiotics Sales Market Share by Application (2017-2028)
5.2 Global Antibiotics Revenue by Application
5.2.1 Global Antibiotics Historical Revenue by Application (2017-2022)
5.2.2 Global Antibiotics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antibiotics Revenue Market Share by Application (2017-2028)
5.3 Global Antibiotics Price by Application
5.3.1 Global Antibiotics Price by Application (2017-2022)
5.3.2 Global Antibiotics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antibiotics Market Size by Type
6.1.1 North America Antibiotics Sales by Type (2017-2028)
6.1.2 North America Antibiotics Revenue by Type (2017-2028)
6.2 North America Antibiotics Market Size by Application
6.2.1 North America Antibiotics Sales by Application (2017-2028)
6.2.2 North America Antibiotics Revenue by Application (2017-2028)
6.3 North America Antibiotics Market Size by Country
6.3.1 North America Antibiotics Sales by Country (2017-2028)
6.3.2 North America Antibiotics Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antibiotics Market Size by Type
7.1.1 Europe Antibiotics Sales by Type (2017-2028)
7.1.2 Europe Antibiotics Revenue by Type (2017-2028)
7.2 Europe Antibiotics Market Size by Application
7.2.1 Europe Antibiotics Sales by Application (2017-2028)
7.2.2 Europe Antibiotics Revenue by Application (2017-2028)
7.3 Europe Antibiotics Market Size by Country
7.3.1 Europe Antibiotics Sales by Country (2017-2028)
7.3.2 Europe Antibiotics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antibiotics Market Size by Type
8.1.1 Asia Pacific Antibiotics Sales by Type (2017-2028)
8.1.2 Asia Pacific Antibiotics Revenue by Type (2017-2028)
8.2 Asia Pacific Antibiotics Market Size by Application
8.2.1 Asia Pacific Antibiotics Sales by Application (2017-2028)
8.2.2 Asia Pacific Antibiotics Revenue by Application (2017-2028)
8.3 Asia Pacific Antibiotics Market Size by Region
8.3.1 Asia Pacific Antibiotics Sales by Region (2017-2028)
8.3.2 Asia Pacific Antibiotics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antibiotics Market Size by Type
9.1.1 Latin America Antibiotics Sales by Type (2017-2028)
9.1.2 Latin America Antibiotics Revenue by Type (2017-2028)
9.2 Latin America Antibiotics Market Size by Application
9.2.1 Latin America Antibiotics Sales by Application (2017-2028)
9.2.2 Latin America Antibiotics Revenue by Application (2017-2028)
9.3 Latin America Antibiotics Market Size by Country
9.3.1 Latin America Antibiotics Sales by Country (2017-2028)
9.3.2 Latin America Antibiotics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antibiotics Market Size by Type
10.1.1 Middle East and Africa Antibiotics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antibiotics Revenue by Type (2017-2028)
10.2 Middle East and Africa Antibiotics Market Size by Application
10.2.1 Middle East and Africa Antibiotics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antibiotics Revenue by Application (2017-2028)
10.3 Middle East and Africa Antibiotics Market Size by Country
10.3.1 Middle East and Africa Antibiotics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antibiotics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Janssen Pharmaceuticals
11.2.1 Janssen Pharmaceuticals Corporation Information
11.2.2 Janssen Pharmaceuticals Overview
11.2.3 Janssen Pharmaceuticals Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Janssen Pharmaceuticals Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Janssen Pharmaceuticals Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Overview
11.4.3 GlaxoSmithKline Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GlaxoSmithKline Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Recent Developments
11.5 Sanofi
11.5.1 Sanofi Corporation Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Sanofi Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Overview
11.6.3 Novartis Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Novartis Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis Recent Developments
11.7 Bayer
11.7.1 Bayer Corporation Information
11.7.2 Bayer Overview
11.7.3 Bayer Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bayer Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bayer Recent Developments
11.8 Bristol Myers Squibb Company
11.8.1 Bristol Myers Squibb Company Corporation Information
11.8.2 Bristol Myers Squibb Company Overview
11.8.3 Bristol Myers Squibb Company Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bristol Myers Squibb Company Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol Myers Squibb Company Recent Developments
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Corporation Information
11.9.2 Eli Lilly and Company Overview
11.9.3 Eli Lilly and Company Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Eli Lilly and Company Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Eli Lilly and Company Recent Developments
11.10 Astellas Pharma
11.10.1 Astellas Pharma Corporation Information
11.10.2 Astellas Pharma Overview
11.10.3 Astellas Pharma Antibiotics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Astellas Pharma Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Astellas Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antibiotics Industry Chain Analysis
12.2 Antibiotics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibiotics Production Mode & Process
12.4 Antibiotics Sales and Marketing
12.4.1 Antibiotics Sales Channels
12.4.2 Antibiotics Distributors
12.5 Antibiotics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antibiotics Industry Trends
13.2 Antibiotics Market Drivers
13.3 Antibiotics Market Challenges
13.4 Antibiotics Market Restraints
14 Key Findings in The Global Antibiotics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Antibiotics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Cephalosporins
    Table 3. Major Manufacturers of Penicillins
    Table 4. Major Manufacturers of Fluoroquinolones
    Table 5. Major Manufacturers of Macrolides
    Table 6. Major Manufacturers of Carbapenems
    Table 7. Major Manufacturers of Aminoglycosides
    Table 8. Major Manufacturers of Sulfonamides
    Table 9. Major Manufacturers of Others
    Table 10. Global Antibiotics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Antibiotics Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 12. Global Antibiotics Sales by Region (2017-2022) & (K Units)
    Table 13. Global Antibiotics Sales Market Share by Region (2017-2022)
    Table 14. Global Antibiotics Sales by Region (2023-2028) & (K Units)
    Table 15. Global Antibiotics Sales Market Share by Region (2023-2028)
    Table 16. Global Antibiotics Revenue by Region (2017-2022) & (US$ Million)
    Table 17. Global Antibiotics Revenue Market Share by Region (2017-2022)
    Table 18. Global Antibiotics Revenue by Region (2023-2028) & (US$ Million)
    Table 19. Global Antibiotics Revenue Market Share by Region (2023-2028)
    Table 20. Global Antibiotics Sales by Manufacturers (2017-2022) & (K Units)
    Table 21. Global Antibiotics Sales Share by Manufacturers (2017-2022)
    Table 22. Global Antibiotics Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 23. Global Antibiotics Revenue Share by Manufacturers (2017-2022)
    Table 24. Antibiotics Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 25. Global Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 26. Global Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotics as of 2021)
    Table 27. Antibiotics Manufacturing Base Distribution and Headquarters
    Table 28. Manufacturers Antibiotics Product Offered
    Table 29. Date of Manufacturers Enter into Antibiotics Market
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Antibiotics Sales by Type (2017-2022) & (K Units)
    Table 32. Global Antibiotics Sales by Type (2023-2028) & (K Units)
    Table 33. Global Antibiotics Sales Share by Type (2017-2022)
    Table 34. Global Antibiotics Sales Share by Type (2023-2028)
    Table 35. Global Antibiotics Revenue by Type (2017-2022) & (US$ Million)
    Table 36. Global Antibiotics Revenue by Type (2023-2028) & (US$ Million)
    Table 37. Global Antibiotics Revenue Share by Type (2017-2022)
    Table 38. Global Antibiotics Revenue Share by Type (2023-2028)
    Table 39. Antibiotics Price by Type (2017-2022) & (USD/Unit)
    Table 40. Global Antibiotics Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 41. Global Antibiotics Sales by Application (2017-2022) & (K Units)
    Table 42. Global Antibiotics Sales by Application (2023-2028) & (K Units)
    Table 43. Global Antibiotics Sales Share by Application (2017-2022)
    Table 44. Global Antibiotics Sales Share by Application (2023-2028)
    Table 45. Global Antibiotics Revenue by Application (2017-2022) & (US$ Million)
    Table 46. Global Antibiotics Revenue by Application (2023-2028) & (US$ Million)
    Table 47. Global Antibiotics Revenue Share by Application (2017-2022)
    Table 48. Global Antibiotics Revenue Share by Application (2023-2028)
    Table 49. Antibiotics Price by Application (2017-2022) & (USD/Unit)
    Table 50. Global Antibiotics Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 51. North America Antibiotics Sales by Type (2017-2022) & (K Units)
    Table 52. North America Antibiotics Sales by Type (2023-2028) & (K Units)
    Table 53. North America Antibiotics Revenue by Type (2017-2022) & (US$ Million)
    Table 54. North America Antibiotics Revenue by Type (2023-2028) & (US$ Million)
    Table 55. North America Antibiotics Sales by Application (2017-2022) & (K Units)
    Table 56. North America Antibiotics Sales by Application (2023-2028) & (K Units)
    Table 57. North America Antibiotics Revenue by Application (2017-2022) & (US$ Million)
    Table 58. North America Antibiotics Revenue by Application (2023-2028) & (US$ Million)
    Table 59. North America Antibiotics Sales by Country (2017-2022) & (K Units)
    Table 60. North America Antibiotics Sales by Country (2023-2028) & (K Units)
    Table 61. North America Antibiotics Revenue by Country (2017-2022) & (US$ Million)
    Table 62. North America Antibiotics Revenue by Country (2023-2028) & (US$ Million)
    Table 63. Europe Antibiotics Sales by Type (2017-2022) & (K Units)
    Table 64. Europe Antibiotics Sales by Type (2023-2028) & (K Units)
    Table 65. Europe Antibiotics Revenue by Type (2017-2022) & (US$ Million)
    Table 66. Europe Antibiotics Revenue by Type (2023-2028) & (US$ Million)
    Table 67. Europe Antibiotics Sales by Application (2017-2022) & (K Units)
    Table 68. Europe Antibiotics Sales by Application (2023-2028) & (K Units)
    Table 69. Europe Antibiotics Revenue by Application (2017-2022) & (US$ Million)
    Table 70. Europe Antibiotics Revenue by Application (2023-2028) & (US$ Million)
    Table 71. Europe Antibiotics Sales by Country (2017-2022) & (K Units)
    Table 72. Europe Antibiotics Sales by Country (2023-2028) & (K Units)
    Table 73. Europe Antibiotics Revenue by Country (2017-2022) & (US$ Million)
    Table 74. Europe Antibiotics Revenue by Country (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Antibiotics Sales by Type (2017-2022) & (K Units)
    Table 76. Asia Pacific Antibiotics Sales by Type (2023-2028) & (K Units)
    Table 77. Asia Pacific Antibiotics Revenue by Type (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Antibiotics Revenue by Type (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Antibiotics Sales by Application (2017-2022) & (K Units)
    Table 80. Asia Pacific Antibiotics Sales by Application (2023-2028) & (K Units)
    Table 81. Asia Pacific Antibiotics Revenue by Application (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Antibiotics Revenue by Application (2023-2028) & (US$ Million)
    Table 83. Asia Pacific Antibiotics Sales by Region (2017-2022) & (K Units)
    Table 84. Asia Pacific Antibiotics Sales by Region (2023-2028) & (K Units)
    Table 85. Asia Pacific Antibiotics Revenue by Region (2017-2022) & (US$ Million)
    Table 86. Asia Pacific Antibiotics Revenue by Region (2023-2028) & (US$ Million)
    Table 87. Latin America Antibiotics Sales by Type (2017-2022) & (K Units)
    Table 88. Latin America Antibiotics Sales by Type (2023-2028) & (K Units)
    Table 89. Latin America Antibiotics Revenue by Type (2017-2022) & (US$ Million)
    Table 90. Latin America Antibiotics Revenue by Type (2023-2028) & (US$ Million)
    Table 91. Latin America Antibiotics Sales by Application (2017-2022) & (K Units)
    Table 92. Latin America Antibiotics Sales by Application (2023-2028) & (K Units)
    Table 93. Latin America Antibiotics Revenue by Application (2017-2022) & (US$ Million)
    Table 94. Latin America Antibiotics Revenue by Application (2023-2028) & (US$ Million)
    Table 95. Latin America Antibiotics Sales by Country (2017-2022) & (K Units)
    Table 96. Latin America Antibiotics Sales by Country (2023-2028) & (K Units)
    Table 97. Latin America Antibiotics Revenue by Country (2017-2022) & (US$ Million)
    Table 98. Latin America Antibiotics Revenue by Country (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Antibiotics Sales by Type (2017-2022) & (K Units)
    Table 100. Middle East and Africa Antibiotics Sales by Type (2023-2028) & (K Units)
    Table 101. Middle East and Africa Antibiotics Revenue by Type (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Antibiotics Revenue by Type (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Antibiotics Sales by Application (2017-2022) & (K Units)
    Table 104. Middle East and Africa Antibiotics Sales by Application (2023-2028) & (K Units)
    Table 105. Middle East and Africa Antibiotics Revenue by Application (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Antibiotics Revenue by Application (2023-2028) & (US$ Million)
    Table 107. Middle East and Africa Antibiotics Sales by Country (2017-2022) & (K Units)
    Table 108. Middle East and Africa Antibiotics Sales by Country (2023-2028) & (K Units)
    Table 109. Middle East and Africa Antibiotics Revenue by Country (2017-2022) & (US$ Million)
    Table 110. Middle East and Africa Antibiotics Revenue by Country (2023-2028) & (US$ Million)
    Table 111. Pfizer Corporation Information
    Table 112. Pfizer Description and Major Businesses
    Table 113. Pfizer Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Pfizer Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Pfizer Recent Developments
    Table 116. Janssen Pharmaceuticals Corporation Information
    Table 117. Janssen Pharmaceuticals Description and Major Businesses
    Table 118. Janssen Pharmaceuticals Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Janssen Pharmaceuticals Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Janssen Pharmaceuticals Recent Developments
    Table 121. Abbott Corporation Information
    Table 122. Abbott Description and Major Businesses
    Table 123. Abbott Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Abbott Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Abbott Recent Developments
    Table 126. GlaxoSmithKline Corporation Information
    Table 127. GlaxoSmithKline Description and Major Businesses
    Table 128. GlaxoSmithKline Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. GlaxoSmithKline Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. GlaxoSmithKline Recent Developments
    Table 131. Sanofi Corporation Information
    Table 132. Sanofi Description and Major Businesses
    Table 133. Sanofi Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Sanofi Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Sanofi Recent Developments
    Table 136. Novartis Corporation Information
    Table 137. Novartis Description and Major Businesses
    Table 138. Novartis Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Novartis Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Novartis Recent Developments
    Table 141. Bayer Corporation Information
    Table 142. Bayer Description and Major Businesses
    Table 143. Bayer Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Bayer Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Bayer Recent Developments
    Table 146. Bristol Myers Squibb Company Corporation Information
    Table 147. Bristol Myers Squibb Company Description and Major Businesses
    Table 148. Bristol Myers Squibb Company Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Bristol Myers Squibb Company Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Bristol Myers Squibb Company Recent Developments
    Table 151. Eli Lilly and Company Corporation Information
    Table 152. Eli Lilly and Company Description and Major Businesses
    Table 153. Eli Lilly and Company Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Eli Lilly and Company Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Eli Lilly and Company Recent Developments
    Table 156. Astellas Pharma Corporation Information
    Table 157. Astellas Pharma Description and Major Businesses
    Table 158. Astellas Pharma Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 159. Astellas Pharma Antibiotics Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Astellas Pharma Recent Developments
    Table 161. Key Raw Materials Lists
    Table 162. Raw Materials Key Suppliers Lists
    Table 163. Antibiotics Distributors List
    Table 164. Antibiotics Customers List
    Table 165. Antibiotics Market Trends
    Table 166. Antibiotics Market Drivers
    Table 167. Antibiotics Market Challenges
    Table 168. Antibiotics Market Restraints
    Table 169. Research Programs/Design for This Report
    Table 170. Key Data Information from Secondary Sources
    Table 171. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antibiotics Product Picture
    Figure 3. Global Antibiotics Market Share by Type in 2021 & 2028
    Figure 3. Cephalosporins Product Picture
    Figure 4. Penicillins Product Picture
    Figure 5. Fluoroquinolones Product Picture
    Figure 6. Macrolides Product Picture
    Figure 7. Carbapenems Product Picture
    Figure 8. Aminoglycosides Product Picture
    Figure 9. Sulfonamides Product Picture
    Figure 10. Others Product Picture
    Figure 11. Global Antibiotics Market Share by Application in 2021 & 2028
    Figure 12. Hospital
    Figure 13. Clinics
    Figure 14. Others
    Figure 15. Antibiotics Report Years Considered
    Figure 16. Global Antibiotics Sales 2017-2028 (K Units)
    Figure 17. Global Antibiotics Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Antibiotics Revenue 2017-2028 (US$ Million)
    Figure 19. Global Antibiotics Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 20. Global Antibiotics Sales Market Share by Region (2017-2022)
    Figure 21. Global Antibiotics Sales Market Share by Region (2023-2028)
    Figure 22. North America Antibiotics Sales YoY (2017-2028) & (K Units)
    Figure 23. North America Antibiotics Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Antibiotics Sales YoY (2017-2028) & (K Units)
    Figure 25. Europe Antibiotics Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Antibiotics Sales YoY (2017-2028) & (K Units)
    Figure 27. Asia-Pacific Antibiotics Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Latin America Antibiotics Sales YoY (2017-2028) & (K Units)
    Figure 29. Latin America Antibiotics Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. Middle East & Africa Antibiotics Sales YoY (2017-2028) & (K Units)
    Figure 31. Middle East & Africa Antibiotics Revenue YoY (2017-2028) & (US$ Million)
    Figure 32. The Antibiotics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 33. The Top 5 and 10 Largest Manufacturers of Antibiotics in the World: Market Share by Antibiotics Revenue in 2021
    Figure 34. Global Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 35. Global Antibiotics Sales Market Share by Type (2017-2028)
    Figure 36. Global Antibiotics Revenue Market Share by Type (2017-2028)
    Figure 37. Global Antibiotics Sales Market Share by Application (2017-2028)
    Figure 38. Global Antibiotics Revenue Market Share by Application (2017-2028)
    Figure 39. North America Antibiotics Sales Market Share by Type (2017-2028)
    Figure 40. North America Antibiotics Revenue Market Share by Type (2017-2028)
    Figure 41. North America Antibiotics Sales Market Share by Application (2017-2028)
    Figure 42. North America Antibiotics Revenue Market Share by Application (2017-2028)
    Figure 43. North America Antibiotics Sales Share by Country (2017-2028)
    Figure 44. North America Antibiotics Revenue Share by Country (2017-2028)
    Figure 45. U.S. Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 46. Canada Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 47. Europe Antibiotics Sales Market Share by Type (2017-2028)
    Figure 48. Europe Antibiotics Revenue Market Share by Type (2017-2028)
    Figure 49. Europe Antibiotics Sales Market Share by Application (2017-2028)
    Figure 50. Europe Antibiotics Revenue Market Share by Application (2017-2028)
    Figure 51. Europe Antibiotics Sales Share by Country (2017-2028)
    Figure 52. Europe Antibiotics Revenue Share by Country (2017-2028)
    Figure 53. Germany Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 54. France Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 55. U.K. Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 56. Italy Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 57. Russia Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 58. Asia Pacific Antibiotics Sales Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Antibiotics Revenue Market Share by Type (2017-2028)
    Figure 60. Asia Pacific Antibiotics Sales Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Antibiotics Revenue Market Share by Application (2017-2028)
    Figure 62. Asia Pacific Antibiotics Sales Share by Region (2017-2028)
    Figure 63. Asia Pacific Antibiotics Revenue Share by Region (2017-2028)
    Figure 64. China Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 65. Japan Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 66. South Korea Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 67. India Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 68. Australia Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 69. Taiwan Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 70. Indonesia Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 71. Thailand Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 72. Malaysia Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 73. Philippines Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 74. Latin America Antibiotics Sales Market Share by Type (2017-2028)
    Figure 75. Latin America Antibiotics Revenue Market Share by Type (2017-2028)
    Figure 76. Latin America Antibiotics Sales Market Share by Application (2017-2028)
    Figure 77. Latin America Antibiotics Revenue Market Share by Application (2017-2028)
    Figure 78. Latin America Antibiotics Sales Share by Country (2017-2028)
    Figure 79. Latin America Antibiotics Revenue Share by Country (2017-2028)
    Figure 80. Mexico Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 81. Brazil Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 82. Argentina Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 83. Middle East and Africa Antibiotics Sales Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Antibiotics Revenue Market Share by Type (2017-2028)
    Figure 85. Middle East and Africa Antibiotics Sales Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Antibiotics Revenue Market Share by Application (2017-2028)
    Figure 87. Middle East and Africa Antibiotics Sales Share by Country (2017-2028)
    Figure 88. Middle East and Africa Antibiotics Revenue Share by Country (2017-2028)
    Figure 89. Turkey Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 90. Saudi Arabia Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 91. U.A.E Antibiotics Revenue (2017-2028) & (US$ Million)
    Figure 92. Antibiotics Value Chain
    Figure 93. Antibiotics Production Process
    Figure 94. Channels of Distribution
    Figure 95. Distributors Profiles
    Figure 96. Bottom-up and Top-down Approaches for This Report
    Figure 97. Data Triangulation
    Figure 98. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global Human Immunodeficiency Virus HIV Therapeutics Market Insights Forecast to 2028
Global Human Immunodeficiency Virus (HIV) Therapeutics Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-28E5708
Thu Mar 24 00:00:00 UTC 2022

Add to Cart

Global HPV Diagnostic Product Market Insights Forecast to 2028
Global HPV Diagnostic Product Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-17A1384
Tue Mar 15 00:00:00 UTC 2022

Add to Cart

Global Syphilis Immunoassay Diagnostics Market Insights Forecast to 2028
Global Syphilis Immunoassay Diagnostics Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-37O5808
Tue Mar 15 00:00:00 UTC 2022

Add to Cart

Global Hepatitis C Drugs Market Insights Forecast to 2028
Global Hepatitis C Drugs Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-1B6342
Mon Mar 14 00:00:00 UTC 2022

Add to Cart